Medicare Rx Means “Dramatic” Change For Pharma; CMS Is New FDA – Scully

The Medicare drug benefit will make the Centers for Medicare & Medicaid Services at least as important to the pharmaceutical market as FDA, former CMS Administrator Tom Scully predicts